N-Methyl-D-Aspartate Antagonists in the Treatment of Parkinson's Disease
Arch Neurol 48:977-981, Greenamyre,J.T.&O'Brien,C.F., 1991
Use of Ibuprofen and Risk of Parkinson Disease
Neurol 76:863-869, Gao,X.,et al, 2011
Nonsteroidal Anti-Inflammatory Drugs and the Incidence of Parkinson Disease
Neurol 66:1097-1099, Hernan,M.A.,et al, 2006
Nonsteroidal Anti-Inflammatory Drugs and the Risk of Parkinson Disease
Arch Neurol 60:1059-1064,1043, Chen,H.,et al, 2003
Exacerbation of Idiopathic Parkinson's Disease by Naproxen
BMJ 311:422, Shaunak,S.,et al, 1995
Neuropsychiatric Systemic Lupus Erythematosus in Elderly People:A Case Series
JNNP 55:1157-1161, Dennis,M.S.,et al, 1992
Acute Exacerbation of Parkinson's Disease with Sulindac
Ann Neurol 17:104-105, Sandyk,R.,et al, 1985
Herpes Simplex Virus Subunit Antibodies in Patients With Parkinson's Disease
Arch Neurol 35:668-671, Marttila,R.J.,et al, 1978
Neurologic Complications of Heroin Addiction
Bull NY Acad Sci 49:4, Ritcher,R.W.,et al, 1973